Press

HDA Links and News

Source: Click here to view press release

DEA – Placement of Tramadol Into Schedule IV

Source: Click here to view press release

Oversight of the U.S. Drug Supply: H.R. 3204, the Drug Quality and Security Act

Source: Click here to view press release

Tramadol is now a Schedule IV Controlled Substance in Georgia

Source: Click here to view press release

A conversation with John M. Gray, Healthcare Distribution Management Assn.

Source: Click here to view press release

HDMA elects new directors to its board

Source: Click here to view press release

Suspicious Order Management

Localized Compliance for Controlled Substance Registrants & Distributors

Federal DEA 21CFR 1301.74b
Suspicious Order Monitoring:
Automatically intercept Orders having significant deviation in:

• Order Size
• Order Frequency
• Order Pattern

Avoid Fines, Cancelled Orders, & Rating Downgrades

Click here to learn more!



D&B BBB HDA SBA NCPA Premier NACDS NMSDC FDA ECRM

Newsletter Sign Up.

Get in touch with us.

Attain Med, Inc.
5825 Glenridge Dr. NE, Bldg. 4, Suite 106
Atlanta, GA 30328

E-mail: information@attainmed.com

Phone: 770-288-2466 | 1 (888) 288-2180
Fax: 1 (888) 288-2181